Trial intelligence / Profile preview

PTAAK: Extended vs Immediate Release Tacrolimus in African American Kidney Transplant Recipients

NCT03841097Phase 4Active, not recruiting

Start
Nov 2019
Primary completion
Dec 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of tacrolimus + Wuzhi capsule in kidney transplant rejection. Started Nov 2019; status: active, not recruiting.

02

Drugs

tacrolimus + Wuzhi capsule
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT03841097.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03841097.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call